Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Influenza Immune Plasma for Severe Influenza
NCT01052480Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2010
- Primary completion
- Mar 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of anti-influenza immune plasma in Influenza A (IAV), influenza B, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2010; status: completed.
02
Drugs
anti-influenza immune plasma
03
Conditions
Influenza A (IAV)influenza B
Beyond the preview
Go deeper on NCT01052480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052480.